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Abstract
Expression of the Bcr-Abl fusion gene in hematopoietic progenitor cells (HPCs) results in
the development of chronic myelogenous leukemia (CML), for which hematopoietic micro-
environment plays an important role. We investigated the specific effects of an HPC line
transduced with Bcr-Abl, KOBA, on BM-derived OP9 stroma cells. DNAmicroarray analysis
revealed that OP9 cells co-cultured with KOBA cells (OP9/L) show diverse changes in
the gene expression. OP9/L cells showed significant down-regulation of Cdkn genes and
up-regulation of Icam1, leading to the increased proliferation capacity of OP9 cells and
enhanced transmigration of leukemia cells through them. The effects were attributed to
direct Notch activation of OP9 cells by KOBA cells. OP9/L cells also showed a markedly
altered cytokine gene expression pattern, including a robust increase in a variety of proin-
flammatory genes and a decrease in hematopoietic cytokines such as Cxcl12, Scf, and
Angpt1. Consequently, OP9/L cells promoted the proliferation of KOBA cells more effi-
ciently than parental OP9 cells, whereas the activity supporting normal myelopoiesis was
attenuated. In mice bearing KOBA leukemia, the characteristic genetic changes observed
in OP9/L cells were reflected differentially in the endothelial cells (ECs) and mesenchymal
stroma cells (MCs) of the BM. The ECs were markedly increased with Notch-target gene
activation and decreased Cdkn expression, whereas the MCs showed a marked increase
in proinflammatory gene expression and a profound decrease in hematopoietic genes.
Human CML cell lines also induced essentially similar genetic changes in OP9 cells. Our
results suggest that CML cells remodel the hematopoietic microenvironment by changing
the gene expression patterns differentially in ECs and MCs of BM.
Introduction
The hematopoietic microenvironment plays crucial roles in normal hematopoiesis [1, 2]. The
stroma cells in the hematopoietic microenvironment represent diverse nonhematopoietic cell
lineages, including mesenchymal stem and progenitor cells, osteoblasts, adipocytes, neuronal
cells, and endothelial cells [3]. The bone marrow (BM) is highly vascular and features a
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sinusoidal structure of endothelial cells (ECs), with mesenchymal stroma cells (MCs) being
located in perivascular regions forming a network between hematopoietic cell islands [4]. The
stroma cells regulate hematopoiesis via direct interactions with hematopoietic cells and secre-
tion of various hematopoietic cytokines [5, 6]. Accumulating evidence indicates that the stroma
cells also affect the growth and spread of leukemia cells arising in the hematopoietic microenvi-
ronment [7–9].
Chronic myelogenous leukemia (CML) is caused by chromosomal translocations leading to
the generation of Bcr-Abl fusion genes. CML stem cells are enriched in the same fraction as
normal hematopoietic stem cells (HSCs) [10–12], and the developmental hierarchy of CML
cells is analogous to that of normal hematopoiesis [13–15]. However, the proliferation and dif-
ferentiation of CML stem/progenitor cells overwhelm normal hematopoiesis, resulting in the
marked accumulation of myeloid progenitors and mature granulocytes. Recent reports suggest
that the CML stem/progenitor cells are regulated by the microenvironment differently from
normal HSCs/hematopoietic progenitor cells (HPCs) [9, 16].
The Rap1 G protein signal plays an important role in cell-cell and cell-matrix interactions
[17]. We previously reported that Bcr-Abl strongly activates Rap1 in CML cells [18], and defi-
ciency of Sipa1, a negative Rap1 regulator, enhances the sustenance of CML stem/progenitors
in vivo [19]. Although the majority of Sipa-1–/–mice develop CML-like myeloproliferative dis-
ease, it occurs only after long latent periods over a year, suggesting the requirement of second-
ary oncogenic hits [20]. It is suggested that Sipa1-deficiency in HPCs predisposes the overt
leukemia genesis by oncogenes including Bcr-Abl.
In the current study, we established a nonleukemic Sipa-1–/–HPC line, KOP1, whose sur-
vival is dependent on OP9 stroma cells representing authentic mesenchymal stem cells [21].
Taking advantage of the strict stroma cell-dependency of KOP1 cells, we investigated the
effects of Bcr-Abl expression in KOP1 cells on the interaction with OP9 cells. We demonstrate
that the KOP1 cells expressing Bcr-Abl, KOBA, induce diverse changes in the gene expression
of OP9 cells through direct interaction, partly via Notch activation, and the effects are reflected
differentially in the primary ECs and MCs of BM invaded by the KOBA cells in vivo. We fur-
ther indicate that human CML cell lines induce essentially the same effects on OP9 cells. Our
results suggest that CML cells remodel the hematopoietic microenvironment by directly chang-
ing the gene expression patterns of distinct types of BM stroma cells.
Results
Bcr-Abl–expressing leukemia cells enhance the proliferation capacity of
OP9 stroma cells
Culture of the BM cells from young Sipa1−/−mice reproducibly resulted in the continuous cell
lines that could be propagated in the presence of BM-derived OP9 stroma cells. These cells,
represented by KOP1, showed immature hematopoietic cell morphology and phenotypes
(Mac1− Gr-1− CD3− B220−/low c-Kit+ CD34− CD43+ BP-1+), probably committed to a B-line-
age (S1 Fig). The survival was absolutely dependent on OP9 cells and was not supported by any
hematopoietic cytokines (S1 Fig). KOP1 cells showed no leukemogenic activity in normal mice
even after the inoculation of 107 cells per mouse (S2 Fig). Taking advantage of the absolute
stroma-dependency, we intended to investigate the effects of Bcr-Abl expression in KOP1 cells
on the interaction with OP9 stroma cells. We retrovirally transduced p210-Bcr-Abl in KOP1
cells (Fig 1A); as expected, the Bcr-Abl+ KOP1 cells, termed KOBA, showed potent leukemo-
genic activity, killing normal mice in 3 weeks with as few as 104 cells per mouse (S2 Fig).
Although KOP1 cells crept underneath OP9 cells forming cobblestones in the co-culture, the
majority of KOBA cells attached but stayed on top surface of OP9 cells (Fig 1B). The survival
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of KOBA cells was no longer OP9-dependent, although the proliferation was significantly
enhanced in the presence of OP9 cells (Fig 1B).
We co-cultured OP9 and KOBA cells for 8 days, recovered the OP9 cells by depleting
KOBA cells (OP9/L), and performed a comparative DNA microarray analysis with untreated
OP9 cells; contamination of KOBA cells was less than 1%. The OP9/L cells showed remarkable
changes in the gene expression compared to control OP9 cells (S1 Table). Among them, we
noticed significantly decreased expression of a series of Cdk inhibitor genes, including Cdkn1a
(Cip1), Cdkn1b (Kip1), Cdkn1c (Kip2), Cdkn2b (Ink4b), and Cdkn3 (Cip2). The effects were
specific for KOBA cells and were barely detected in the OP9 cells co-cultured with parental
KOP1 cells (OP9/P), as confirmed by quantitative RT-PCR (Fig 1C). Immunostaining analysis
indicated reduced nuclear expression of Cip1 and Kip2 in OP9/L cells (Fig 1D). In agreement
with the findings, OP9/L, but not OP9/P, cells showed significantly enhanced proliferation
capacity compared to control OP9 cells (Fig 1E). It was also noted that such proliferating OP9/
L cells showed an increased expression of CD34 (Fig 1E), which is associated with neovascular-
ization in BM [22]. The results suggest that Bcr-Abl+ leukemic cells specifically enhance the
proliferation capacity of OP9 stroma cells by repressing Cdkn expression.
KOBA cells enhance the proliferation capacity of OP9 cells by activating
Notch signal
OP9/L cells showed a remarkable increase in the Notch-target genes, Hes1,Hey1, andHey2,
compared with OP9 and OP9/P cells; the expression of these genes was negligible in KOBA
Fig 1. Bcr-Abl+ KOBA leukemia cells repress the expression of Cdk inhibitors and enhance the proliferation of OP9 stroma cells. (a) KOP1 and
KOBA were immunostained with anti-GFP antibody and DAPI. (b) KOP1 and KOBA cells (1 × 105 cells) were co-cultured with OP9 cells. KOP1 cells crawled
under OP9 cells, forming a cobblestone pattern, whereas KOBA cells were on top of them. Viable cell numbers of KOP1 and KOBA cells in the absence or
presence of OP9 cells on day 4 are also shown. The means and standard errors (SEs) of triplicate culture. (c) Expression of indicated genes was determined
in OP9, OP9/L, and OP9/P cells using quantitative RT-PCR. The means and SEs of triplicate determination. *P < 0.05 and **P < 0.01. (d) OP9 and OP9/L
cells were immunostained with anti-Cip1 and anti-Kip2 along with DAPI. (e) OP9, OP9/L, and OP9/P cells (100 cells) were cultured alone, and the viable cell
numbers were counted on day 8. NS, not significant.
doi:10.1371/journal.pone.0134026.g001
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cells and was not attributable to the minimal contamination by KOBA cells (Fig 2A). OP9 cells
expressed Notch receptors, and KOBA cells expressed Notch ligands (Jagged1 and Dll1)
(Fig 2B). Co-culture of KOBA cells with Notch-responsive C2C12 myoblast cells caused signifi-
cant activation of Notch1 in the C2C12 cells, indicating that the ligands on KOBA cells were
functional (Fig 2B). We confirmed that OP9/L showed a higher expression of Hes-1 protein
compared with OP9 and OP9/P cells, to the extent comparable with that in the OP9 cells stim-
ulated with Dll4-Ig fusion protein (Fig 2C). Further, the Hes-1 induction by the co-culture with
KOBA cells was almost completely inhibited in the presence of a γ-secretase inhibitor (DAPT)
at 15 μM (Fig 2C). We then examined the effects of DAPT on the Cdkn expression in OP9
cells. The repression of Cdkn1a, Cdkn1b, and Cdkn3 by the co-culture with KOBA cells was
abolished nearly completely in the presence of 15 μMDAPT (Fig 2D). Concordantly, enhance-
ment of the proliferation capacity was also abrogated in the presence of DAPT, although the
proliferation capacity of OP9 cells in the absence KOBA was unaffected (Fig 2E). We con-
firmed that the proliferation of OP9 cells was significantly enhanced in the presence of Dll4-Ig
Fig 2. KOBA cells repressCdkn expression and enhance proliferation of OP9 cells by Notch activation. (a) Expression of indicated Notch target
genes was determined in OP9, OP9/L, OP9/P, and KOBA cells were determined using quantitative RT-PCR. The means and SEs of triplicate determination.
*P < 0.01. (b) Cell surface expression of Notch receptors and ligands was analyzed in OP9 and KOBA cells, respectively, using FACS. Shaded areas
indicate control staining (left). C2C12 myoblast cells were co-cultured with or without KOBA cells for 8 days, andNotch1 transcripts in isolated C2C12 were
determined by quantitative RT-PCR (right). The means and SEs of triplicate culture. *P < 0.05. (c) OP9, OP9/L, OP9/P, and OP9 cells cultured with coated
Dll4-Ig protein were lysed and immunoblotted with anti-Hes1 and anti-actin antibodies (upper). Arrowhead indicate Hes1 signal at 31 kDa, and relative signal
densities of Hes1 over actin are shown. OP9 cells were co-cultured with KOBA cells in the absence or continuous presence of varying concentrations of
DAPT for 8 days, and the isolated OP9 cells were lysed and immunoblotted with anti-Hes1 antibody (lower). Arrowhead indicate Hes1 signal, and relative
signal densities of Hes1 over Actin are shown. (d) Expression of indicatedCdkn genes was determined in OP9, OP9/L, and OP9/L induced in the presence
of 15 μMDAPT. The means and SEs of triplicate determination. (e) OP9 cells (1 × 104 cells) were cultured alone or with KOBA cells in the absence or
presence of 15 μMDAPT for 8 days and the viable cell numbers were counted (left). OP9 cells (1 × 104 cells) were also cultured with or without coated Dll4-Ig
for 8 days, and the viable cell numbers were counted (right). The means and SEs of triplicate culture are shown.
doi:10.1371/journal.pone.0134026.g002
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(Fig 2E). We also examined the reversibility of the effects. OP9 cells were co-cultured with
KOBA cells for 13 days, and aliquots of the cultures were treated with 10 μM imatinib for 2
days from day 8 to 10, which killed essentially all KOBA cells without affecting OP9 cells in the
culture. The increase ofHes1/Hey1 and decrease of Cdkn’s were almost completely returned to
the levels of control OP9 cells by the imatinib treatment (S3A Fig). The results strongly suggest
that KOBA cells enhance the proliferation capacity of OP9 cells by directly activating Notch
signal.
KOBA cells induce altered expression of the ligands for integrins in OP9
cells
OP9 cells express a high level of VCAM-1, a ligand for α4/β1 integrin, but only a minimal level
of ICAM-1, a ligand for αL/β2 integrin. However, OP9/L, but not OP9/P, cells showed a
remarkable increase in Icam1 transcripts and accordingly, significantly increased cell-surface
expression of ICAM-1 (Fig 3A and 3B). DAPT treatment significantly impaired the increase in
ICAM-1 expression, suggesting the involvement of Notch activation (Fig 3B). In contrast,
Fig 3. OP9/L cells show characteristic changes in integrin receptor expression and altered integrin-mediated interaction with KOBA cells. (a) The
expression of Icam1 and Vcam1 in OP9, OP9/L, and OP9/L was determined by quantitative RT-PCR. The means and SEs of triplicate determination are
shown. *P < 0.01. (b) OP9, OP9/L, and OP9/L (+DAPT) cells were analyzed for the surface expression of indicated molecules with FACS. Shaded areas
indicate control staining. (c) Expression of LFA-1 on KOBA cells was analyzed with two-color FACS using anti-αL and anti-β2 integrin antibodies (left). KOBA
cells were cultured on OP9 or OP9/L cell monolayers in a matrigel invasion chamber for 16 hours, and the cells that transmigrated the filters were counted
(right). The means and SEs of triplicate culture are shown. (d) Expression of VLA-4 on KOBA cells was analyzed with two-color FACS using anti-α4 and anti-
β1 integrin antibodies (left). KOBA cells were cultured on OP9 or OP9/L cell monolayers for 6 hours, and the cells that stably attached onto the monolayers
were counted (right). The means and SEs of triplicate culture are shown.
doi:10.1371/journal.pone.0134026.g003
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expression of VCAM-1 was rather decreased in OP9/L cells, and the effect was not affected by
DAPT (Fig 3B). Since Vcam1 transcripts were unaffected, the expression change of VCAM-1
was apparently posttranscriptional. The expressions of β1-integrin and β3-integrin were also
reduced slightly (Fig 3B). We then examined the functional consequences of the altered expres-
sion of integrin ligands on the interaction with KOBA cells, which expressed both αL/β2
(LFA1) and α4/β1 (VLA-4) integrins (Fig 3C and 3D). KOBA cells showed significantly
enhanced transmigration through OP9/L cells, probably mediated by LFA-1 [23], compared
with OP9 cells (Fig 3C), whereas the stable adhesion to OP9/L cells, most likely via VLA-4
[24], was remarkably reduced (Fig 3D). The results indicate that the interaction of OP9 cells
with KOBA cells renders the stroma cells more supportive for leukemia cell migration at the
cost of static adhesion.
KOBA cells induce a change in the cytokine gene expression pattern of
OP9 cells
Notable changes in OP9/L cells were also detected in the expression of genes coding various
cytokines. The OP9/L cells had a remarkable increase in the transcripts of proinflammatory
factors, including various chemokines (Ccl1, Ccl2, Ccl5, Ccl7, Cxcl1, Cxcl5), complement ele-
ments, IL-6, Spp1, and Vegfa, compared with control OP9 cells (Fig 4A). In contrast, the
Fig 4. OP9/L cells show increased proinflammatory factor and decreased hematopoietic factor gene expression and enhance KOBA cell
proliferation at the cost of supporting normal hematopoiesis. (a) OP9, OP9/L, and OP9/P cells were analyzed for the expression of indicated cytokine
genes with quantitative RT-PCR. The means and SEs of triplicate determination are shown. *P < 0.01. (b)OP9, OP9/L, and OP9/L (+15 μMDAPT) cells
were cultured for 3 days, and indicated cytokines in the culture supernatants were assessed with enzyme-linked immunosorbent assay. The means and SEs
of triplicate culture are shown. *P < 0.05. (c) KOBA cells (1 × 103 cells) were cultured with OP9 or OP9/L cell monolayers, and the viable cell numbers were
counted on indicated days. The means and SEs of triplicate culture are shown. (d) Sorted lin− BM cells (105 cells) from normal B6 mice were cultured with
OP9 or OP9/L cell monolayers for 5 days, and total recovered cell numbers were counted. An aliquot of the cells was analyzed with two-color FACS for
indicated lineage markers, and the cell numbers of lin− and mature hematopoietic cells were also assessed.
doi:10.1371/journal.pone.0134026.g004
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expression of genes crucially involved in normal hematopoiesis, such as Scf, Cxcl12, and
Angpt1, was significantly decreased (Fig 4A). Again, the effects were specific for KOBA cells,
and OP9/P cells barely showed such changes, except for a rather increased Angpt1 expression.
We confirmed that OP9/L cells secreted significantly more Ccl5 and OPN and much less
Cxcl12 and Scf than OP9 cells (Fig 4B). The altered cytokine pattern was unaffected by DAPT
and was apparently independent of Notch activation (Fig 4B). Further, unlike the Cdkn repres-
sion via Notch activation, the effects on cytokine genes lasted longer, for at least 3 days after
the depletion of KOBA cells with imatinib (S3B Fig). OP9/L cells showed significantly
increased expression of a series of genes related to adipocyte differentiation including Cebpb
and adipokines (S4 Fig) and thus, the diverse effects on cytokine expression may be partly asso-
ciated with adipocytic differentiation of OP9 cells. We also investigated the functional conse-
quences of the effects. The proliferation of KOBA cells was significantly enhanced in the
presence of OP9/L cells compared to control OP9 cells (Fig 4C). In contrast, OP9/L cells
showed significantly attenuated activity for supporting the hematopoiesis from normal lin−
BM cells, particularly the generation of mature granulocytes (Fig 4D). The results suggest that
KOBA cells induce a markedly altered repertoire of cytokine production in OP9 cells, which
contributes to the overall promotion of leukemia cell proliferation over normal hematopoiesis.
KOBA cells differentially affect the proliferation and gene expression of
primary ECs and MCs in vivo in BM
We then examined the effects of KOBA cells on the primary stroma cells in BM by inoculating
KOBA cells in normal, unirradiated mice (5 × 103 cells per mouse). As GFP+ KOBA cells
colonized and expanded in BM by day 14, the absolute numbers of GFP−CD45+ normal
hematopoietic cells were profoundly decreased (Fig 5A). However, the total numbers of CD45−
PDFGRβ+ MCs were maintained, and those of CD45− CD31+ ECs were even significantly
increased (Fig 5A). Immunostaining analysis revealed that the ECs as detected with CD105
expression were increased locally in the regions coinciding with the leukemic cell foci at as
early as 8 days (Fig 5B). Both ECs and MCs expressed Notch receptors and showed a significant
increase inHes1 /Hey1 expression compared with those in normal BM (S5 Fig and Fig 6A).
Further, ECs, but not MCs, showed significantly decreased expression of Cdkn1b and Cdkn11c
similar to OP9/L cells, which is consistent with the preferential increase in ECs (Fig 6A). On
the other hand, MCs showed a reduced expression of Cxcl12 and Angpt1 and a remarkable
increase in the expression of inflammatory cytokine genes, such as Spp1, Il-6, Ccl2, Ccl7, Cxcl1,
and C3, again reminiscent of OP9/L cells (Fig 6A). ECs barely expressed these cytokine genes
either in normal or in leukemic mice, except for Il-6, which was strikingly increased in the ECs
of leukemic BM (Fig 6A). MCs and ECs also revealed distinct changes in the expression of cell-
adhesion molecules. ECs showed increased CD34, which is characteristic of CML-associated
angiogenesis in human, and decreased VCAM-1 and β3-integrin, whereas MCs exhibited a
markedly increased expression of ICAM-1 and CD44 (Fig 6B). Altogether, these results suggest
that the effects of KOBA cells on OP9 cells in vitro were differentially reflected on the primary
ECs and MCs of BM in vivo during the leukemic invasion.
Notch ligands on KOBA cells is involved in the increased ECs in BM and
the leukemic expansion
To examine the involvement of Notch ligands (NLs) on KOBA cells in their leukemogenic
activity, we separated the NL− and NL+ KOBA cells with the use of a cell-sorter and inoculated
them separately in normal mice (5x103 cells per mouse). Co-culture of each fraction with OP9
cells in vitro confirmed thatHes1/Hey1 activation and Cdkn repression in OP9 cells were
Stroma Cell Remodeling by CML
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observed only in the NL+ KOBA cells (S6 Fig). Although the sorted KOBA/NL− cells gradually
restored the NL expression during the propagation in culture, the levels remained to be lower
than in KOBA/NL+ cells for at least 8 days at least in culture. Upon inoculation into normal
mice, GFP+ KOBA/NL+ cells showed significantly more expansion in BM than KOBA/NL−
cells at day 12 (Fig 7A). The significant increase in ECs in BM was observed only in the KOBA/
NL+-bearing mice (Fig 7A). The expression of CD34 in ECs as well as the increase in CD44
and ICAM1 expression in MCs were also detected in the mice inoculated with KOBA/NL+
cells (Fig 7B). These results suggest that the expression of NLs on KOBA cells contributes to
the leukemogenic activity in vivo by affecting the microenvironmental stroma cells.
Human CML cell lines alter the gene expression of OP9 cells similarly to
KOBA cells
We finally examined whether human CML cells also show the effects on stroma cells. It was
confirmed that two independent CML cell lines, K562 and MEG01, expressed Notch ligands,
Jagged 1 and Jagged 2 (Fig 8A). Taking the advantage of effective Notch interaction between
human and murine cells [25], we co-cultured the human CML cells with OP9 cells. Both OP9/
K562 and OP9/MEG01 cells showed significantly increased proliferation capacity compared to
untreated OP9 cells (Fig 8B). Moreover, OP9/K562 and OP9/MEG01 cells showed markedly
Fig 5. The numbers of ECs are increased around KOBA leukemia cells in BM. (a) Normal unirradiated
B6 mice were injected intravenously with KOBA cells (3 × 103 cells/mouse), and the BM cells were analyzed
with two-color FACS for the expression of indicated molecules before and 8 and 14 days after the inoculation
(left). The proportions of GFP+ KOBA cells, CD45− PDGFRβ+ MCs, and CD45− CD31+ ECs are indicated.
The means and SEs of total GFP− CD45+, EC, and MC cell numbers in five recipients were assessed (right).
*P < 0.01. (b) The femoral bones of before and 8 days after KOBA inoculation were immunostained with anti-
GFP and anti-CD105 antibodies. Enlarged images of the boxed regions are indicated.
doi:10.1371/journal.pone.0134026.g005
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altered gene expression, including increased expression of Notch target genes (Hes1,Hey1,
Hey2) and proinflammatory genes (Il-6, Ccl2, Ccl7 and Vegfa), and decreased expression of
Cdk inhibitor genes (Cdkn1b, Cdkn1c, Cdkn3) and hematopoietic genes (Scf, Angpt1, Cxcl12)
(Fig 8C). The effects were stronger in MEG01 cells than K562 cells. The OP9/MEG01 cells also
exhibited increased ICAM1 and CD44 expression with reduced β3-integrin (Fig 8D). These
results indicate that human CML cell lines can induce similar characteristic genetic changes in
OP9 stroma cells.
Discussion
In the current study, we investigated the effects of CML cells on the hematopoietic microenvi-
ronment. To examine the specific effects of Bcr-Abl on the interaction with stroma cells, we
established a set of cell lines, a stroma-dependent, nonleukemic hematopoietic cell line (KOP1)
Fig 6. Leukemic invasion of KOBA cells induces distinctive effects on the gene expression and phenotypes of ECs and MCs in BM. (a) ECs and
MCs were sorted from the BM of mice 14 days after KOBA cell inoculation, and the expression of indicated genes was determined with quantitative RT-PCR.
The means and SEs from three mice are shown. P < 0.05. (b) The surface expression of indicated molecules was analyzed with multi-color FACS in the
CD31+ (EC) and PDGFRβ+ (MC) cell gates before (black line) and 14 days after (red line) KOBA inoculation. Shaded areas indicate control staining.
doi:10.1371/journal.pone.0134026.g006
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and a KOP1 line transformed by Bcr-Abl expression (KOBA) and compared the effects on OP9
stroma cells representing MSCs.
The OP9 cells co-cultured with KOBA cells (OP9/L), but not with KOP1 cells (OP9/P),
showed significant repression of Cdkn genes and increased proliferation capacity, and the effect
was associated with the activation of Notch target genes including Hes1,Hey1, and Hey2. Fur-
ther, OP9 and KOBA cells expressed Notchs and Notch ligands (NLs), most strongly Jagged1,
respectively, and the Cdkn repression as well as the growth promotion was almost completely
abrogated in the presence of a γ-secretase inhibitor (DAPT) during the co-culture. It is
reported that Hes1 and Hey1 directly repress the transcription of Cdkn genes [26, 27], and
thus, it is strongly suggested that the effect is mediated by Notch activation via KOBA cells. In
addition, OP9/L cells showed a remarkable increase in Icam1 transcripts with enhanced cell
surface expression of ICAM-1, and the effect was also attenuated by DAPT. A recent report
indicated that Notch1 stimulation of glioblastoma stem cells resulted in the enhanced
Fig 7. KOBA-NL+, but barely KOBA-NL–, cells induce the increase in EC numbers and altered
expression of adherencemolecules. (a) KOBA cells were separated into NL+ and NL− fractions with a cell-
sorter. Normal unirradiated B6 mice were injected intravenously with the sorted KOBA cells (3 × 103 cells/
mouse), and the BM cells were analyzed with two-color FACS for the expression of indicated molecules 12
days later (left). The proportions of GFP+ KOBA cells, CD45− PDGFRβ+ MCs, and CD45− CD31+ ECs are
indicated. The means and SEs of total KOBA, EC, and MC cell numbers in 3 recipients were assessed (right).
(b) The surface expression of indicated molecules was analyzed with multi-color FACS in the CD45– CD31+
(EC) and CD45– PDGFRβ+ (MC) cell gates 12 days after KOBA inoculation. Shaded areas indicate control
staining.
doi:10.1371/journal.pone.0134026.g007
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expression of ICAM-1 [28]. In agreement with the findings, KOBA cells expressing αL/
β2-integrin, a receptor for ICAM-1, exhibited much more efficient transmigration through
OP9/L cells than through OP9 cells. These results suggest that the Bcr-Abl+ leukemia cells
actively modify the proliferation capacity and function of OP9 stroma cells by activating Notch
signal.
OP9/L cells also showed characteristic changes in the expression of a wide range of cytokine
genes. Thus, OP9/L cells expressed markedly reduced transcripts of Scf, Cxcl12, and Angpt1
and secreted less amounts of SCF and CXCL12, which are crucial for supporting normal hema-
topoiesis [6, 29], than parental OP9 cells. In concordance with the findings, OP9/L cells showed
significantly attenuated activity to support the proliferation and differentiation of normal lin−
BM cells, particularly granulocyte development, in vitro. The decreased expression of VCAM-
1, β1-integrin, and β3-integrin in OP9/L cells may additionally contribute to the effects [30,
Fig 8. Human CML cell lines induce the changes in gene expression patterns of OP9 stroma cells on the co-culture. (a) K562 and MEG01, were
analyzed for the expression of Notch ligands with FACS. Shaded areas indicate control staining. (b)OP9 cells were co-cultured with K562 or MEG01 cells.
Eight days later, the CML cells were depleted, and the isolated OP9 cells were cultured (0.5×105 cells) alone. The viable cell numbers were counted on day
4. (c)OP9 cells precultured alone, with K562, or MEG01 cells for 8 days were isolated, and the expression of indicated genes were analyzed with quantitative
RT-PCR. The means and SEs of triplicate determination are shown. *P < 0.05. (d)OP9 cells precultured alone or with MEG01 cells for 8 days were isolated,
and the expression of indicated molecules were analyzed with FACS.
doi:10.1371/journal.pone.0134026.g008
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31]. In contrast, OP9/L cells revealed a remarkably increased expression of many proinflamma-
tory cytokine genes, including various chemokine genes, IL6, Spp1, and Vegfa, compared to
the parental OP9 and OP9/P cells. Accumulating evidence indicates that a proinflammatory
microenvironment favors the expansion of leukemic cells including CML [16, 32], and an
important role of IL-6 in the progression of CML has also been reported [16, 33]. We found
that OP9/L cells supported the KOBA cell proliferation significantly better than control OP9
cells in vitro, and our preliminary results indicate that the culture supernatant of OP9/L cells
alone was capable of enhancing their proliferation (Supper E and Minato N, unpublished
observations). The change in the cytokine gene expression pattern was resistant to DAPT treat-
ment and was apparently Notch-independent. It is reported that CXCL12-abundant reticular
(CAR) cells, which are crucial for normal hematopoiesis, represent mesenchymal progenitors
with the potential for terminal differentiation into adipocytes and chondrocytes [34]. Because
OP9/L cells showed increased expression of Cebpb and several adipokine genes, it may be pos-
sible that the altered cytokine pattern is related to the differentiation induction via KOBA cells.
The assumption may be consistent with the finding that the changes in cytokine genes lasted
longer after KOBA cell removal than Notch-mediated effects. In any case, these results suggest
that KOBA cells induce a functional remodeling of OP9 stroma cells, which benefits the leuke-
mia cell proliferation at the cost of normal hematopoiesis.
Such characteristic changes in the gene expression of OP9/L cells were recapitulated in pri-
mary stroma cells after KOBA cell invasion in BM, although the effects were quite distinctive
in ECs and MCs. The number of ECs was markedly increased around the leukemic cell foci in
BM. The ECs showed a significant increase inHes/Hey1 expression along with the repression
of Cdkn1b/Cdkn1c, which is consistent with Notch activation. Indeed, the effects were hardly
observed when sorted KOBA/NL− cells were inoculated, indicating that the hypervascularity
was attributed to Notch activation in ECs via leukemia cells. Similar to OP9/L cells, the primary
ECs in KOBA-bearing mice showed increased CD34 expression, which is characteristic of new
angiogenesis in human CML [35], implying that these ECs are derived in part fromMSCs via
transdifferentiation [36] [37]. The effects of KOBA invasion on the expression of cell-adhesion
molecules were also distinct between ECs and MCs in vivo. Among the changes observed in
OP9/L cells, the increase in ICAM1 and CD44 expression was detected exclusively in MCs,
whereas the reduced expression of VCAM-1 and β3-integrin was seen only in ECs. Although
both ECs and MCs showed the activation ofHes1/Hey1, it appears that the consequences of
Notch activation vary in the context of stroma cell types. Importantly, KOBA/NL+ cells
expanded more efficiently than KOBA/NL− cells in BM, suggesting that the Notch-mediated
modification of BM stroma cells plays a significant role in the leukemic cell expansion (S7 Fig).
The prominent changes in the cytokine gene expression observed in OP9/L cells, including
decreased hematopoietic genes and a remarkable increase in proinflammatory genes, were
observed almost exclusively in MCs. The profound decrease of Cxcl12 is consistent with the
deregulation of normal hematopoiesis commonly associated with CML [38]. Ccl2 and Ccl5
have been reported to be involved in the mobilization and homing of MCs to tumor sites and
to participate in the maintenance of a proinflammatory state that favors tumor growth as well
as metastatic colonization [39, 40]. An only exception was Il-6, which is reported to be acti-
vated by CML cells and to play an important role in CML development [16], and ECs showed a
remarkable increase in Il-6, even more so than MCs. Such an altered cytokine milieu in BM
may favor CML promotion over normal hematopoiesis (S7 Fig).
We demonstrated that human CML cell lines also expressed NLs and induced the changes
in the gene expression of OP9 stroma cells essentially identical to those by murine KOBA cells.
Thus, MEG01, and to less extent K562, cells induced a potent activation of Notch-target genes
and caused repression of Cdkns and activation of Icam1in OP9 cells by the co-culture. The
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CML cells also induced a marked repression of hematopoietic genes with a concomitant
increase of proinflammatory cytokine genes. It would be quite feasible that CML cells induce
the remodeling of BMmicroenvironment favoring the CML cell proliferation and spread in
humans as well. Intervening the effects of CML cells on BM stroma cells may provide an alter-
native therapeutic target controlling human CML.
Materials and Methods
Mice
C57BL/6 (B6) mice at the ages of 8 to 10 weeks were purchased from Japan SLC, Kyoto, Japan.
Sipa1−/−mice [20] and B6 mice were maintained in specific pathogen-free conditions at Labo-
ratory Animals Center, Kyoto University in accordance with the Institutional Animal Care and
Use Committee (IACUC) Guidelines of Kyoto University Graduate School of Medicine. The
mice were sacrificed by spinal cord dislocation under anesthesia with isoflurane. The protocol
was approved by the IACUC of Kyoto University Graduate School of Medicine. All efforts
were made to minimize suffering.
Cell lines
The KOP1 cell line was established from the BM of 8-month-old Sipa1−/−mice with no myelo-
proliferative disease. The BM cells were cultured in complete BXH2 medium (Dulbecco’s mod-
ified Eagle’s medium [DMEM] supplemented with 10% heat-inactivated fetal calf serum, 10%
NTC-109, 50 μM 2-mercaptoethanol, 100 μM nonessential amino acids, 1 mM sodium pyru-
vate, and antibiotics) for 2 weeks, and the cobblestone-like cells were passaged on OP9 cell
monolayers every week to develop a continuous cell line. The KOP1 cell line was infected with
a pMCs-ires-EGFP retroviral vector containing p210 Bcr-Abl cDNA as previously reported [19]
(ref. 19), to establish the KOBA cell line. OP9 stroma cells were maintained in α-MEM (Invi-
trogen, Carlsbad, CA) supplemented with 20% etal bovine serum (FBS). The Notch-responsive
C2C12 cell line was maintained in DMEM supplemented with 10% FBS. The human CML cells
lines, K562 and MEG01, were kindly provided by Dr. A. Takaori, Department of Hematology,
Graduate School of Medicine, Kyoto University, Japan, and were maintained in RMPI supple-
mented with 10% FBS.
Cell cultures
KOP1 or KOBA cells (106 cells) were co-cultured with OP9 cell monolayers in 10-cm dishes in
complete BXH2 medium. After 5 days, overgrown KOBA cells were depleted with gentle
pipetting from the culture every 2 days. After 8 days, the cultures were treated with trypsin/
EDTA and stained with FITC-anti-CD45 antibody, and then CD45− OP9 cells were isolated
using FACSAria II (BD Biosciences) or AutoMax (Miltenyl Biotec, Bergisch Gladbach, Ger-
many). In the OP9 cells co-cultured with KOP1 and KOBA cells were called OP9/P and OP9/
L, respectively. For in vitro hematopoiesis, B6 BM cells were stained with a mixture of lineage
markers (anti-CD45, anti-Ter119 [Biolegend] anti-CD3, anti-CD4, anti-CD8, anti-Mac-1,
anti-Gr-1, anti-B220, and anti-NK.1.1 [BD Biosciences]), and the lin− cells were isolated using
AutoMax and cultured on OP9 or OP9/L cell monolayers for 5 days. For the Notch ligand
assay, C2C12 cell monolayers were cultured in the absence or presence of KOBA cells for 2
days, and the CD45− C2C12 cells were isolated using AutoMax. K562 or MEG-01 cells (106
cells) were co-cultured with OP9 cell monolayers in 10-cm dishes in RPMI medium. After 8
days, the cultures were treated with trypsin/EDTA, stained with human FITC-anti-CD45RA
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and APC-anti-CD45RO antibody, and CD45− OP9 cells were isolated using AutoMax (Milte-
nyl Biotec, Bergisch Gladbach, Germany).
Flow cytometry
Flow cytometric analysis of the OP9 cells and primary BM cells were performed with the use
of FACSCanto (Becton Dickinson, San Jose, CA). The following antibodies were used: anti-
PDGFRβ, anti-CD31, anti-CD45, anti-Ter119, anti-CD54 (Biolegend), anti-CD3, anti-CD4,
anti-CD8, anti-CD34, anti-Mac-1, anti-Gr-1, anti-B220, and anti-TER-119, anti-NK.1.1, anti-
CD106 anti-hCDRA (BD Biosciences), and anti-CD61 anti-CD140a (eBioscience) anti-CD44
anti-hCD45RO (Pharmingen), anti-Notch-1, anti-Notch-4, anti-Jagged-1 (eBioscience), anti-
Notch-2, anti-Notch-3, anti-Dll-1, and anti-jagged-2 (Biolegend).
DNAmicroarray analysis
RNA was extracted from OP9 and purified OP9/L cells with Trizol and subjected to DNA
microarray analysis in oligomer chips covering 20,000 genes by TaKaRa Bio Inc. (Siga, Japan).
Data were filtered to remove low-confidence measurements and were globally normalized per
array.
Quantitative PCR
Total RNA was extracted with Trizol extraction followed by cDNA synthesis with SuperScript
III (Invitrogen). Real-time PCR was performed with a LightCycler SYBR Green I marker kit on
a LightCycler instrument (Roche, Basel, Switzerland). Cyclosporin served as an internal con-
trol. The primer pairs are listed in S2 Table.
Immunoblotting and immunostaining
Cells were lysed with RIPA buffer (150 mMNaCl, 25 mM Tris-HCl [pH 7.6], 1% NP-40, 1%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, protease, and phosphatase inhibitors) and
immunoblotted with anti-p27/Kip1 (Cell Signaling Technology, Beverly, MA, USA), anti-Hes-
1, and anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). For immunostaining of
OP9 cells, the cells cultured on cover slips were fixed with 3% formalin, permeabilized with
0.02% Triton, blocked with 4% bovine serum albumin (BSA) in phosphate-buffered saline
(PBS), and incubated overnight with anti-p21/Cip1 or anti-p57/Kip2 antibody (Upstate Co.,
Billercia, MA, USA), followed by Cy3-conjugated anti-mouse or Cy3-conjugated anti-rat (Jack-
son ImmunoResearch) IgG, along with DAPI. The images were visualized using a ZEISS Axio-
vert200M microscope equipped with an Axiocam MRm camera (Carl Zeiss MicroImaging,
Göttingen, Germany). For staining BM, the femoral bones were fixed in 2% paraformaldehyde
and left overnight in 30% sucrose before being snap-frozen in optimum cutting temperature
compound; frozen sections were fixed with acetone. After blocking with BSA (1% in PBS), sam-
ples were stained with anti-GFP and anti-CD105 (eBioscence) antibodies followed by second-
ary antibodies Cy3-conjugated anti-rat IgG and Alexa Fluor 488–conjugated anti-rabbit IgG
(Invitrogen) along with DAPI, and mounted in Mowiol (Calbiochem). Images were acquired
with the use of fluorescence microscopy (Axiovert 200M) equipped with an AxioCamMRm
Fluar 2.5×/0.12 or 5×/0.25 numerical aperture objective lens (Carl Zeiss) and analyzed with
AxioVision version 4.6 (Carl Zeiss). Digital images were processed using Adobe Photoshop
CS2 (Adobe Systems).
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Cell migration and adhesion assay
The migration potential of KOBA cells was evaluated using a BD BioCoat Matrigel Invasion
Chamber. KOBA cells (105 cells) were plated on OP9 or OP9/L monolayers in a matrigel inva-
sion chamber and incubated for 16 hours. The under-surfaces of the filters were gently rinsed
with PBS followed by fixation in 100% methanol and stained with Giemsa solution. The sam-
ples were examined with a microscope (Carl Zeiss) and the numbers of KOBA from the OP9/L
co-culture cells per field in three wells were counted. For cell adhesion, KOBA cells (106 cells)
were cultured for 6 hours on OP9 or OP9/L cell monolayers at 37°C in BXH2 medium. The
floating cells were aspirated and gently rinsed with warm PBS twice to eliminate the weakly
attached KOBA cells. The cultures were treated with trypsin/EDTA, and the remaining KOBA
cells were counted.
Reagents
The γ-secretase inhibitor (GSI) (DAPT, Calbiochem, San Diego, CA) and Imatinib mesylate
(Gleevec, STI571, Novartis) were obtained commercially.
Statistical analysis
Statistical analysis was performed using a Student t-test.
Supporting Information
S1 Fig. KOP1 cell line represents immature hematopoietic cells, whose survival is abso-
lutely dependent on OP9 stroma cells. (a) KOP1 cells cultured in the presence of OP9 cells
were immunostained with indicated antibodies (left), and those separated from OP9 cells were
cytospun and stained with Giemza solution (right). (b) KOP1 cells were two-color analyzed for
the expression of indicated markers with FACS. (c) Genomic PCR analysis of Sipa1 and neo in
the gene targeting vector of KOP1 as well as B6 and Sipa-1–/– BM cells. (d) KOP1 cells were
detached from OP9 cells, cultured in the absence of OP9 stroma cells for indicated periods,
and were analyzed for the expression of indicated markers (upper) as well as DNA contents
(lower). The progressive increase in apoptotic cells is noted with little change in the cell cycle
pattern of viable cells.
(TIF)
S2 Fig. Expression of Bcr-Abl in KOP1 cells results in the potent leukemogenic activity in
vivo. Normal B6 mice (14 mice/group) were inoculated with KOP1 (107 cells/mouse) or
KOBA (104 cells/mouse) cells, and the survival rates were examined.
(TIF)
S3 Fig. The effects of KOBA cells on the cytokine gene expression of OP9 cells last longer
than the Notch-mediated effects. OP9 cells were cultured in the absence of presence of KOBA
cells for 13 days, with depletion of overgrown KOBA cells every 2 days. At day 8, imatinib
(10μM) was added in aliquots of cultures for 2 days, and then replaced with fresh medium. On
day 13, the OP9 cells were recovered by depleting KOBA cells, and the transcripts of indicated
genes were examined with qRT-PCR. The vast majority of KOBA cells died in 24 hours after
imatinib addition, whereas OP9 cells were barely affected. The means and SE of triplicate deter-
mination are indicated.
(TIF)
S4 Fig. OP9/L cells show increased expression of adipocyte-related genes. Expression of
indicated genes was determined in OP9, OP9/L, and OP9/P cells using quantitative RT-PCR.
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The means and SEs of triplicate determination are shown. P< 0.05.
(TIF)
S5 Fig. Both primary ECs and MCs in BM express Notch receptors. Cell surface expression
of Notch receptors was analyzed for primary ECs and MCs from BM with FACS. Shaded areas
indicate control staining.
(TIF)
S6 Fig. NL+, but barely NL–, KOBA cells are capable of inducingHes1/Hey1 and repressing
Cdkn’s of OP9 stroma cells. KOBA cells were stained with the mixture of anti-NL (Jagged1,
Jagged2, Dll-1) antibodies, and the NL+ and NL− fractions were sorted as indicated with FACS
AriaIII. Each fraction was cultured in the presence of OP9 cells for 8 days, OP9 cells were
recovered after depleting CD45+ KOBA cells with AutoMax, and the expression of indicated
genes were determined by quantitative RT-PCR. The means and SEs of triplicate determination
are shown.
(TIF)
S7 Fig. Bcr-Abl+ leukemia cells differentially affect the gene expression of ECs and MCs in
BM. Bcr-Abl+ leukemia cells directly activate Notch signal, leading to the repression of Cdk
inhibitor genes in ECs and neovasculogenesis. It is possible that the increase in ECs also
involves the transdifferentiation fromMSCs associated with CD34 expression. Notch activa-
tion in MCs causes increased ICAM1 expression, promoting the leukemia cell migration. Also,
Bcr-Abl+ leukemia cells repress the hematopoietic genes but remarkably enhance the expres-
sion of diverse proinflammatory genes in MCs. The effects are Notch-independent and may
involve the differentiation promotion to adipocytes. Such a drastic change in the cytokine
milieu may favor the expansion of leukemia cells at the cost of normal hematopoiesis in the
BM. HSPC; hematopoietic stem/progenitor cell.
(TIF)
S1 Table. Altered gene expression in OP9 cells by the coculture with KOBA.
(PDF)
S2 Table. List of the primer pairs
(PDF)
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